The efficacy and safety of low dose apixaban in patients with non-valvular atrial fibrellation in real world practive: a prospective, multicenter , non-interventional study
Not Applicable
Recruiting
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0005916
- Lead Sponsor
- Keimyung University Dongsan Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1673
Inclusion Criteria
1)Adult patients over 19 years of age.
2)Patients diagnosed with non-valvular atrial fibrillation atrial
3)Patients who are taking low-capacity Apixaban with anticoagulant therapy within the last six months of the date of consent in accordance with the drug manual , Patients who did not have a history of the primary and secondary evaluation variables, Clinical Event, or who are scheduled to take Apixaban after taking it
4) Patients with a CHA 2 DS2 VASc score of 2 or higher or male patients with a CHA 2 DS2 VASc score of 1
5) Patients who meet at least two of the three criteria below
A. Cr = 1.5mg /
B. age =80 years
C. weight =60 kg
Exclusion Criteria
1) Those vulnerable to clinical research (Follow KGCP definition)
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method